Pulmonary resection for lung cancer in patients with idiopathic interstitial pneumonia

Annals of Thoracic Surgery

Volumn 100, Issue 3, 2015, Pages 954-960

  Omori, Takahiro ^a   Tajiri, Michihiko ^a   Baba, Tomohisa ^a   Ogura, Takashi ^a   Iwasawa, Tae ^a   Okudela, Koji ^b   Takemura, Tamiko ^c   Oba, Mari S ^b   Maehara, Takamitsu ^d   Nakayama, Haruhiko ^e   Tsuboi, Masahiro ^f   Masuda, Munetaka ^b  

^a Kanagawa Prefectural Cardiovascular and Respiratory Diseases Center Hospital   (Japan)

^b YOKOHAMA CITY UNIVERSITY   (Japan)

^c JAPANESE RED CROSS MEDICAL CENTER   (Japan)

^d YOKOHAMA ROSAI HOSPITAL   (Japan)

^e KANAGAWA CANCER CENTER   (Japan)

^f NATIONAL CANCER CENTER HOSPITAL EAST   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

AGED; ARTICLE; CAUSE OF DEATH; CONTROLLED STUDY; FEMALE; FORCED EXPIRATORY VOLUME; FORCED VITAL CAPACITY; HUMAN; INTERSTITIAL PNEUMONIA; LONG TERM SURVIVAL; LUNG RESECTION; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD; MORBIDITY; NON SMALL CELL LUNG CANCER; OVERALL SURVIVAL; PRIORITY JOURNAL; RESPIRATORY FAILURE; RESPIRATORY FUNCTION; RETROSPECTIVE STUDY; SURGICAL MORTALITY; SURVIVAL RATE; CARCINOMA, NON-SMALL-CELL LUNG; COMPLICATION; LUNG NEOPLASMS;

AGED; CARCINOMA, NON-SMALL-CELL LUNG; FEMALE; HUMANS; IDIOPATHIC INTERSTITIAL PNEUMONIAS; LUNG NEOPLASMS; MALE; PNEUMONECTOMY; RETROSPECTIVE STUDIES;

EID: 84940722422     PISSN: 00034975     EISSN: 15526259     Source Type: Journal    
DOI: 10.1016/j.athoracsur.2015.03.094     Document Type: Article

References (29)

1. American Thoracic Society/European Respiratory Society International Multidisciplinary Consensus Classification of the Idiopathic Interstitial Pneumonias. This joint statement of the American Thoracic Society (ATS), and the European Respiratory Society (ERS) was adopted by the ATS board of directors, June 2001, and by the ERS Executive Committee, June 2001 Am J Respir Crit Care Med 165 2002 277 304
2. J.A. Bjoraker, J.H. Ryu, M.K. Edwin, and et al. Prognostic significance of histopathologic subsets in idiopathic pulmonary fibrosis Am J Respir Crit Care Med 157 1998 199 203
3. A.G. Nicholson, T.V. Colby, R.M. Dubois, D.M. Hansell, and A.U. Wells The prognostic significance of the histologic pattern of interstitial pneumonia in patients presenting with the clinical entity of cryptogenic fibrosing alveolitis Am J Respir Crit Care Med 162 2000 2213 2217
4. K.R. Flaherty, G.B. Toews, W.D. Travis, and et al. Clinical significance of histological classification of idiopathic interstitial pneumonia Eur Respir J 19 2002 275 283
5. R.M. Rudd, R.J. Prescott, J.C. Chalmers, and I.D.A. Johnston British Thoracic Society study on cryptogenic fibrosing alveolitis: response to treatment and survival Thorax 62 2007 62 66
6. T.E. King, J.A. Tooze, M.I. Schwarz, K.R. Brown, and R.M. Cherniack Predicting survival in idiopathic pulmonary fibrosis: scoring system and survival model Am J Respir Crit Care Med 164 2001 1171 1181
7. E.R. Fernández Pérez, C.E. Daniels, D.R. Schroeder, and et al. Incidence, prevalence, and clinical course of idiopathic pulmonary fibrosis: a population-based study Chest 137 2010 129 137
8. G. Raghu, H.R. Collard, J.J. Egan, and et al. An official ATS/ERS/JRS/ALAT statement: idiopathic pulmonary fibrosis: evidence-based guidelines for diagnosis and management Am J Respir Crit Care Med 183 2011 788 824
9. K.R. Flaherty, E.L. Thwaite, E.A. Kazerooni, and et al. Radiological versus histological diagnosis in UIP and NSIP: survival implications Thorax 58 2003 143 148
10. R. Hubbard, A. Venn, S. Lewis, and J. Britton Lung cancer and cryptogenic fibrosing alveolitis: a population-based cohort study Am J Respir Crit Care Med 161 2000 5 8
11. Y. Ozawa, T. Suda, T. Naito, and et al. Cumulative incidence of and predictive factors for lung cancer in IPF Respirology 14 2009 723 728
12. H. Kawasaki, K. Nagai, J. Yoshida, M. Nishimura, and Y. Nishiwaki Postoperative morbidity, mortality, and survival in lung cancer associated with idiopathic pulmonary fibrosis J Surg Oncol 81 2002 33 37
13. M. Chiyo, Y. Sekine, T. Iwata, and et al. Impact of interstitial lung disease on surgical morbidity and mortality for lung cancer: analyses of short-term and long-term outcomes J Thorac Cardiovasc Surg 126 2003 1141 1146
14. A. Watanabe, T. Higami, S. Ohori, T. Koyanagi, S. Nakashima, and T. Mawatari Is lung cancer resection indicated in patients with idiopathic pulmonary fibrosis? J Thorac Cardiovasc Surg 136 2008 1357 1363
15. Y. Saito, Y. Kawai, N. Takahashi, and et al. Survival after surgery for pathologic stage IA non-small cell lung cancer associated with idiopathic pulmonary fibrosis Ann Thorac Surg 92 2011 1812 1818
16. H. Taniguchi, M. Ebina, Y. Kondoh, and et al. Pirfenidone in idiopathic pulmonary fibrosis Eur Respir J 35 2010 821 829
17. T. Fujimoto, T. Okazaki, T. Matsukura, and et al. Operation for lung cancer in patients with idiopathic pulmonary fibrosis: surgical contraindication? Ann Thorac Surg 76 2003 1674 1679
18. Y. Minegishi, K. Takenaka, H. Mizutani, and et al. Exacerbation of idiopathic interstitial pneumonias associated with lung cancer therapy Intern Med 48 2009 665 672
19. P. Kumar, P. Goldstraw, K. Yamada, and et al. Pulmonary fibrosis and lung cancer: risk and benefit analysis of pulmonary resection J Thorac Cardiovasc Surg 125 2003 1321 1327
20. T. Sato, S. Teramukai, H. Kondo, and et al. Impact and predictors of acute exacerbation of interstitial lung diseases after pulmonary resection for lung cancer J Thorac Cardiovasc Surg 147 2014 1604 1611
21. K. Koizumi, T. Hirata, K. Hirai, and et al. Surgical treatment of lung cancer combined with interstitial pneumonia: the effect of surgical approach on postoperative acute exacerbation Ann Thorac Cardiovasc Surg 10 2004 340 346
22. T. Hiraki, H. Gobara, H. Mimura, Y. Matsui, S. Toyooka, and S. Kanazawa Percutaneous radiofrequency ablation of clinical stage I non-small cell lung cancer J Thorac Cardiovasc Surg 142 2011 24 30
23. H.R. Collard, T.E. King, B.B. Bartelson, J.S. Vourlekis, M.I. Schwarz, and K.K. Brown Changes in clinical and physiologic variables predict survival in idiopathic pulmonary fibrosis Am J Respir Crit Care Med 168 2003 538 542
24. R.M. du Bois, D. Weycker, C. Albera, and et al. Ascertainment of individual risk of mortality for patients with idiopathic pulmonary fibrosis Am J Respir Crit Care Med 184 2011 459 466
25. A.C. Best, J. Meng, A.M. Lynch, and et al. Idiopathic pulmonary fibrosis: physiologic tests, quantitative CT indexes, and CT visual scores as predictors of mortality Radiology 246 2008 935 940
26. C.J. Lettieri, S.D. Nathan, S.D. Barnett, S. Ahmad, and A.F. Shorr Prevalence and outcomes of pulmonary arterial hypertension in advanced idiopathic pulmonary fibrosis Chest 129 2006 746 752
27. A. Yokoyama, K. Kondo, M. Nakajima, and et al. Prognostic value of circulating KL-6 in idiopathic pulmonary fibrosis Respirology 11 2006 164 168
28. T.E. King, W.Z. Bradford, S. Castro-Bernardini, and et al. A phase 3 trial of pirfenidone in patients with idiopathic pulmonary fibrosis N Engl J Med 370 2014 2083 2092
29. L. Richeldi, R.M. du Bois, G. Raghu, and et al. Efficacy and safety of nintedanib in idiopathic pulmonary fibrosis N Engl J Med 370 2014 2071 2082